Key benefits
- Unique quantification of Fetomaternal Hemorrhage by flow cytometry
- Complete assay, ready to use
- Simple and easy handling procedure
- FETALtrol™ available as a system control
Features
- Double discrimination between fetal cells and maternal HbF+ cells
- Detection as low as 0.014% fetal cells in maternal blood
- Based on the patented combination of antibodies against fetal hemoglobin and carbonic anhydrase
- Results in 90 minutes
- Registered as Medical Device for In Vitro Diagnostic Use (IVD/CE)
Applications
- Determination of Fetomaternal Hemorrhage
- Pregnancy with suspected RhD incompatibilities
- Abdominal trauma